GENE ONLINE|News &
Opinion
Blog

2025-04-28|

Scientists work toward a vaccine for filoviruses, Ebola’s deadly kin

by Mark Chiang
Share To

NEWSFLASH

**Title: Researchers Investigate Vaccine Development for Filoviruses, Including Ebola and Marburg**

Scientists are actively working to develop a vaccine targeting filoviruses, a family of viruses known for their extreme lethality. These pathogens, which include the Ebola and Marburg viruses, have posed significant challenges to global health since their discovery decades ago. Despite more than 50 years of research following the identification of the Marburg virus and nearly half a century since the first recorded outbreak of Ebola, many aspects of these viruses remain poorly understood.

Filoviruses are classified as some of the most dangerous pathogens in existence, requiring handling exclusively in high-security laboratories due to their potential risks. The ongoing research aims to address critical gaps in knowledge about this virus family while advancing efforts toward vaccine development. Scientists hope that deeper insights into filoviruses will pave the way for effective prevention measures against outbreaks caused by these deadly agents.

Newsflash | Powered by GeneOnline AI

Source: https://medicalxpress.com/news/2025-04-scientists-vaccine-filoviruses-ebola-deadly.html

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
R&D
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
LATEST
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top